NCT02521207View on ClinicalTrials.gov

Pilot Study of OXP001(2) and Brufen in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

August 31, 2015

Study Completion Date

September 30, 2015

Conditions
Gastroduodenal Erosions
Interventions
DRUG

Ibuprofen

Trial Locations (1)

NG11 6JS

Quotient Clinical Ltd, Nottingham

Sponsors

Collaborators (1)

Quotient Clinical
All Listed Sponsors
collaborator

Quotient Clinical

OTHER

lead

Oxford Pharmascience Ltd

INDUSTRY

NCT02521207 - Pilot Study of OXP001(2) and Brufen in Healthy Subjects | Biotech Hunter | Biotech Hunter